Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1989-03-02
1991-09-10
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
560 37, 560 42, 564153, 564156, A61K 4904
Patent
active
050472283
ABSTRACT:
Nonionic compounds of the formula ##STR1## wherein X is --CONR.sub.1 R.sub.2, --COOR.sub.3, --CH.sub.2 NHR.sub.7 or --CH.sub.2 OH; Y is --1R.sub.1 R.sub.2 or --OR.sub.3 ; and Z is --NR.sub.1 R.sub.2, --NHR.sub.7 or --OR.sub.3 ; and wherein R.sub.1 R.sub.2 and R.sub.3 in X, Y or Z, and R.sub.7 in X and Z, are identical or different, R.sub.1 and R.sub.2, and each is hydrogen, C.sub.1-6 -alkyl or C.sub.2-8 - alkyl substituted by 1-5 OH groups and/or by a C.sub.1-3 -alkoxy group; R.sub.3 is C.sub.1-4 -alkyl or C.sub.2-4 -alkyl substituted by 1-2 OH groups and/or by a C.sub.1-3 -alkoxy group; and R.sub.7 is an acyl group of a C.sub.2-5 OH group and/or by a C.sub.1-3 -alkoxy group are highly advantageous X-ray contrast agents.
REFERENCES:
patent: 4001323 (1977-01-01), Felder
patent: 4021481 (1977-05-01), Almen
patent: 4062934 (1977-12-01), Tilley
patent: 4250113 (1981-02-01), Nordal
patent: 4269819 (1981-05-01), Gries
Gries Heinz
Mutzel Wolfgang
Pfeiffer Heinrich
Speck Ulrich
Schering Aktiengesellschaft
Shippen Michael L.
LandOfFree
Nonionic 5-C-substituted 2,4,6-triiodoisophthalic acid derivativ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nonionic 5-C-substituted 2,4,6-triiodoisophthalic acid derivativ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonionic 5-C-substituted 2,4,6-triiodoisophthalic acid derivativ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-538762